Polygenic risk scores: from research tools to clinical instruments

Полигенные показатели риска: от исследовательских инструментов к клиническим инструментам
Cathryn M. Lewis, Evangelos Vassos
2020-05-18

clinical utilitydisease susceptibilitygenome-wide association studiesnon-European ancestrypolygenic risk scores
Genome-wide association studies have shown unequivocally that common complex disorders have a polygenic genetic architecture and have enabled researchers to identify genetic variants associated with diseases. These variants can be combined into a polygenic risk score that captures part of an individual's susceptibility to diseases. Polygenic risk scores have been widely applied in research studies, confirming the association between the scores and disease status, but their clinical utility has yet to be established. Polygenic risk scores may be used to estimate an individual's lifetime genetic risk of disease, but the current discriminative ability is low in the general population. Clinical implementation of polygenic risk score (PRS) may be useful in cohorts where there is a higher prior probability of disease, for example, in early stages of diseases to assist in diagnosis or to inform treatment choices. Important considerations are the weaker evidence base in application to non-European ancestry and the challenges in translating an individual's PRS from a percentile of a normal distribution to a lifetime disease risk. In this review, we consider how PRS may be informative at different points in the disease trajectory giving examples of progress in the field and discussing obstacles that need to be addressed before clinical implementation.
1
Clinical implementation is limited by weaker evidence in non-European ancestries and difficulties translating percentile scores into lifetime disease risk.
2
Clinical usefulness may be greater in high-prior-probability settings, including early disease stages for diagnosis or treatment selection.
3
Current polygenic risk scores have low discriminative ability for estimating disease risk in the general population.
4
Polygenic risk scores combine disease-associated variants to capture part of an individual’s genetic susceptibility to common complex disorders.
5
Research studies consistently associate polygenic risk scores with disease status, but their clinical utility has not yet been established.

polygenic risk scores for common complex disorders

their clinical utility, discriminative ability, and implementation across the disease trajectory

Publication Details
Publication Date
2020-05-18
Journal
Publisher
ISSN
Cited by
1355
Access Type
Author Information
Authors
Cathryn M. Lewis
Evangelos Vassos
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%